Isosteviol Sodium (STVNA) Reduces Pro-Inflammatory Cytokine IL-6 and GM-CSF in an In Vitro Murine Stroke Model of the Blood-Brain Barrier (BBB)
Early treatment with glucocorticoids could help reduce both cytotoxic and vasogenic edema, leading to improved clinical outcome after stroke. In our previous study, isosteviol sodium (STVNA) demonstrated neuroprotective effects in an in vitro stroke model, which utilizes oxygen-glucose deprivation (...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_c7a2040ce42e4c3695e9d6564a9d133c | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Moritz Reschke |e author |
| 700 | 1 | 0 | |a Ellaine Salvador |e author |
| 700 | 1 | 0 | |a Nicolas Schlegel |e author |
| 700 | 1 | 0 | |a Malgorzata Burek |e author |
| 700 | 1 | 0 | |a Srikanth Karnati |e author |
| 700 | 1 | 0 | |a Christian Wunder |e author |
| 700 | 1 | 0 | |a Carola Y. Förster |e author |
| 245 | 0 | 0 | |a Isosteviol Sodium (STVNA) Reduces Pro-Inflammatory Cytokine IL-6 and GM-CSF in an In Vitro Murine Stroke Model of the Blood-Brain Barrier (BBB) |
| 260 | |b MDPI AG, |c 2022-08-01T00:00:00Z. | ||
| 500 | |a 10.3390/pharmaceutics14091753 | ||
| 500 | |a 1999-4923 | ||
| 520 | |a Early treatment with glucocorticoids could help reduce both cytotoxic and vasogenic edema, leading to improved clinical outcome after stroke. In our previous study, isosteviol sodium (STVNA) demonstrated neuroprotective effects in an in vitro stroke model, which utilizes oxygen-glucose deprivation (OGD). Herein, we tested the hypothesis that STVNA can activate glucocorticoid receptor (GR) transcriptional activity in brain microvascular endothelial cells (BMECs) as previously published for T cells. STVNA exhibited no effects on transcriptional activation of the glucocorticoid receptor, contrary to previous reports in Jurkat cells. However, similar to dexamethasone, STVNA inhibited inflammatory marker IL-6 as well as granulocyte-macrophage colony-stimulating factor (GM-CSF) secretion. Based on these results, STVNA proves to be beneficial as a possible prevention and treatment modality for brain ischemia-reperfusion injury-induced blood-brain barrier (BBB) dysfunction. | ||
| 546 | |a EN | ||
| 690 | |a IL-6 | ||
| 690 | |a ischemia | ||
| 690 | |a isosteviol sodium (STVNA) | ||
| 690 | |a dexamethasone | ||
| 690 | |a glucocorticoid receptor | ||
| 690 | |a cerebEND | ||
| 690 | |a Pharmacy and materia medica | ||
| 690 | |a RS1-441 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Pharmaceutics, Vol 14, Iss 9, p 1753 (2022) | |
| 787 | 0 | |n https://www.mdpi.com/1999-4923/14/9/1753 | |
| 787 | 0 | |n https://doaj.org/toc/1999-4923 | |
| 856 | 4 | 1 | |u https://doaj.org/article/c7a2040ce42e4c3695e9d6564a9d133c |z Connect to this object online. |